Barclays’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-13,638
| Closed | -$381K | – | 4504 |
|
|
2019
Q3 | $381K | Sell |
13,638
-32,686
| -71% | -$913K | ﹤0.01% | 2755 |
|
|
2019
Q2 | $653K | Buy |
46,324
+42,657
| +1,163% | +$601K | ﹤0.01% | 2584 |
|
|
2019
Q1 | $33K | Buy |
3,667
+3,529
| +2,557% | +$31.8K | ﹤0.01% | 3803 |
|
|
2018
Q4 | $1K | Sell |
138
-7,796
| -98% | -$56.5K | ﹤0.01% | 4059 |
|
|
2018
Q3 | $167K | Buy |
7,934
+2,665
| +51% | +$56.1K | ﹤0.01% | 3165 |
|
|
2018
Q2 | $158K | Buy |
5,269
+1,816
| +53% | +$54.5K | ﹤0.01% | 2864 |
|
|
2018
Q1 | $93K | Buy |
3,453
+2,336
| +209% | +$62.9K | ﹤0.01% | 3198 |
|
|
2017
Q4 | $32K | Sell |
1,117
-12,246
| -92% | -$351K | ﹤0.01% | 3532 |
|
|
2017
Q3 | $324K | Buy |
+13,363
| New | +$324K | ﹤0.01% | 2144 |
|